Skip to main content
Clinical Trials/ACTRN12616001359426
ACTRN12616001359426
Completed
未知

The effectiveness of hyperbaric oxygen therapy on pure tone audiogram outcome of patients with sudden sensorineural hearing loss. A prospective, randomized, interventional, controlled clinical trial.

Medical School of Aristotle University of Thessaloniki0 sites50 target enrollmentSeptember 29, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Medical School of Aristotle University of Thessaloniki
Enrollment
50
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 29, 2016
End Date
September 23, 2019
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Medical School of Aristotle University of Thessaloniki

Eligibility Criteria

Inclusion Criteria

  • Idiopathic sudden sensorineural hearing loss

Exclusion Criteria

  • 1\)Patients with bilateral sudden sensorineural hearing loss.
  • 2\)Patients who seek assistance after more than 7 days from the presence of symptoms.
  • 3\)Patients who have already received another treatment for sudden sensorineural hearing loss.
  • 4\)Patients with other causes of sudden sensorineural hearing loss such as autoimmune disease, Meniere disease, use of ototoxic agents, syphilis, trauma.
  • 5\)Acoustic neuroma or demyelinating disease in MRI or other lesion in the cerebellopontine angle.
  • 6\)Patients younger than 18 years old.
  • 7\)Pregnancy.
  • 8\) Contraindications to HBOT such as tension or untreated or recent pneumothorax, administration of certain drugs (Bleomycin, Cisplatin, Disulfiram, Doxorubicin), untreated epilepsy or seizures, congenital spherocytosis, upper respiratory infection, heart failure, chronic obstructive pulmonary disease, claustrophobia.
  • 9\)Glaucoma.
  • 10\)Mental disorders.

Outcomes

Primary Outcomes

Not specified

Similar Trials